New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 10, 2014
11:44 EDTPCLN, GILDStocks with call strike movement; PCLN GILD
Priceline (PCLN) July 1490 call option implied volatility increased 6% to 35, Gilead (GILD) August 82.5 call option implied volatility increased 5% to 82.5 according to IVolatility.
News For PCLN;GILD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 14, 2014
09:38 EDTGILDActive equity options trading
Subscribe for More Information
06:19 EDTPCLNStocks with implied volatility below IV index mean; PCLN NFLX
Subscribe for More Information
November 13, 2014
13:32 EDTGILDLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
13:29 EDTGILDLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
13:26 EDTGILDLeerink biotech analysts hold an analyst/industry conference call
Biotech Analysts provide a preview of items being discussed at the upcoming 56th Annual Meeting of ASH including Leukemia/MDS on an Analyst/Industry conference call to be held on November 20 at 10 am.
06:05 EDTPCLNStocks with implied volatility below IV index mean; PCLN V
Subscribe for More Information
November 12, 2014
07:53 EDTGILDLeerink to hold a tour
Subscribe for More Information
05:58 EDTPCLNStocks with implied volatility below IV index mean; PCLN V
Stocks with implied volatility below IV index mean; Priceline (PCLN) 20, Visa (V) 18 according to iVolatility.
November 11, 2014
16:14 EDTGILDLeerink biotech analysts hold an analyst/industry conference call
Biotech Analysts provide a preview of items being discussed at the upcoming 56th Annual Meeting of ASH including JAK inhibitors, novel Jakafi combinations for Myelofibrosis and developing compounds on an Analyst/Industry conference call to be held on November 17 at 10 am.
16:01 EDTGILDOptions Update; November 11, 2014
Subscribe for More Information
11:35 EDTGILDUBS holds a conference call with Gilead Sciences
UBS Biotech Analyst Roden, along with Dr. Bischofberger of Gilead Sciences, discuss the recently-held AASLD Meeting and the outlook of several GILD pipeline programs on a conference call to be held on November 13 at 4:30 pm.
08:07 EDTGILDGilead announces results from Phase 2 and 3 studies evaluating Harvoni
Subscribe for More Information
08:05 EDTGILDGilead announces data from Phase 2 Sofosbuvir plus GS-5816 studies
Subscribe for More Information
05:58 EDTPCLNStocks with implied volatility below IV index mean; PCLN V
Subscribe for More Information
November 10, 2014
16:00 EDTGILDOptions Update; November 10, 2014
Subscribe for More Information
09:35 EDTGILDActive equity options trading
Subscribe for More Information
09:20 EDTGILDOn The Fly: Pre-market Movers
Subscribe for More Information
08:48 EDTGILDGilead rises after Merck presents data on HCV combo
Subscribe for More Information
07:20 EDTGILDGilead overhang from Merck HCV combo removed, says Wells Fargo
Subscribe for More Information
05:59 EDTPCLNPriceline guidance cuts usually buying opportunities, says Piper Jaffray
Piper Jaffray says that over the last six years there have been three other instances where Priceline guided the mid-point of bookings growth more than 500 basis points below consensus, and that each time proved to be "excellent opportunities to buy" the stock. Piper reiterates an Overweight rating on Priceline after the company guided Q4 well below consensus on November 4.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use